Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 172493, 7 pages
http://dx.doi.org/10.1155/2015/172493
Review Article

P2X7 Receptor as a Key Player in Oxidative Stress-Driven Cell Fate in Nonalcoholic Steatohepatitis

Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, University of South Carolina, Columbia, SC 29208, USA

Received 31 December 2014; Accepted 17 February 2015

Academic Editor: Peter Backx

Copyright © 2015 Saurabh Chatterjee and Suvarthi Das. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Reaven, “Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease,” Circulation, vol. 106, no. 3, pp. 286–288, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Gallagher, D. Leroith, and E. Karnieli, “Insulin resistance in obesity as the underlying cause for the metabolic syndrome,” Mount Sinai Journal of Medicine, vol. 77, no. 5, pp. 511–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Chen, F. He, H. L. Zhou, H. R. Wu, C. Xia, and Y. M. Li, “Relationship between nonalcoholic fatty liver disease and metabolic syndrome,” Journal of Digestive Diseases, vol. 12, no. 2, pp. 125–130, 2011. View at Publisher · View at Google Scholar
  5. C. E. Kelley, A. J. Brown, A. M. Diehl, and T. L. Setji, “Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome,” World Journal of Gastroenterology, vol. 20, no. 39, pp. 14172–14184, 2014. View at Publisher · View at Google Scholar
  6. N. Chalasani, Z. Younossi, J. E. Lavine et al., “The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association,” Hepatology, vol. 55, no. 6, pp. 2005–2023, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Angulo, “Treatment of nonalcoholic fatty liver disease,” Annals of Hepatology, vol. 1, no. 1, pp. 12–19, 2002. View at Google Scholar · View at Scopus
  8. G. Vernon, A. Baranova, and Z. M. Younossi, “Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults,” Alimentary Pharmacology & Therapeutics, vol. 34, no. 3, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B. N. Bohinc and A. M. Diehl, “Mechanisms of disease progression in NASH: new paradigms,” Clinics in Liver Disease, vol. 16, no. 3, pp. 549–565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Rosso, N. C. Chavez-Tapia, C. Tiribelli, and S. Bellentani, “Translational approaches: from fatty liver to non-alcoholic steatohepatitis,” World Journal of Gastroenterology, vol. 20, no. 27, pp. 9038–9049, 2014. View at Publisher · View at Google Scholar
  11. A. M. Diehl, “Hepatic complications of obesity,” Gastroenterology Clinics of North America, vol. 39, no. 1, pp. 57–68, 2010. View at Publisher · View at Google Scholar
  12. M. Pasarín, V. La Mura, J. Gracia-Sancho et al., “Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD,” PLoS ONE, vol. 7, no. 4, Article ID e32785, 2012. View at Publisher · View at Google Scholar
  13. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two “Hits”?” Gastroenterology, vol. 114, no. 4, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Q. Yang, H. Z. Lin, M. D. Lane, M. Clemens, and A. M. Diehl, “Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 6, pp. 2557–2562, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Yamaguchi, L. Yang, S. McCall et al., “Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis,” Hepatology, vol. 45, no. 6, pp. 1366–1374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Choi and A. M. Diehl, “Hepatic triglyceride synthesis and nonalcoholic fatty liver disease,” Current Opinion in Lipidology, vol. 19, no. 3, pp. 295–300, 2008. View at Publisher · View at Google Scholar
  17. M. F. Abdelmalek and A. M. Diehl, “Nonalcoholic fatty liver disease as a complication of insulin resistance,” The Medical Clinics of North America, vol. 91, no. 6, pp. 1125–1149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Bugianesi, S. Moscatiello, M. F. Ciaravella, and G. Marchesini, “Insulin resistance in nonalcoholic fatty liver disease,” Current Pharmaceutical Design, vol. 16, no. 17, pp. 1941–1951, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Bugianesi, C. Zannoni, E. Vanni, R. Marzocchi, and G. Marchesini, “Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?” Digestive and Liver Disease, vol. 36, no. 3, pp. 165–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Tilg and A. R. Moschen, “Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis,” Hepatology, vol. 52, no. 5, pp. 1836–1846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Sumida, E. Niki, Y. Naito, and T. Yoshikawa, “Involvement of free radicals and oxidative stress in NAFLD/NASH,” Free Radical Research, vol. 47, no. 11, pp. 869–880, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Gawrieh, E. C. Opara, and T. R. Koch, “Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies,” Journal of Investigative Medicine, vol. 52, no. 8, pp. 506–514, 2004. View at Google Scholar · View at Scopus
  23. L. A. Videla, R. Rodrigo, J. Araya, and J. Poniachik, “Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease,” Trends in Molecular Medicine, vol. 12, no. 12, pp. 555–558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Videla, R. Rodrigo, J. Araya, and J. Poniachik, “Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease,” Free Radical Biology and Medicine, vol. 37, no. 9, pp. 1499–1507, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Aubert, K. Begriche, L. Knockaert, M. A. Robin, and B. Fromenty, “Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 10, pp. 630–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Orellana, R. Rodrigo, N. Varela et al., “Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients,” Hepatology Research, vol. 34, no. 1, pp. 57–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Niki, “Lipid peroxidation: physiological levels and dual biological effects,” Free Radical Biology & Medicine, vol. 47, no. 5, pp. 469–484, 2009. View at Publisher · View at Google Scholar
  28. L. Malaguarnera, R. Madeddu, E. Palio, N. Arena, and M. Malaguarnera, “Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients,” Journal of Hepatology, vol. 42, no. 4, pp. 585–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Sutti, A. Jindal, I. Locatelli et al., “Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH,” Hepatology, vol. 59, no. 3, pp. 886–897, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa, “In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases,” Journal of Hepatology, vol. 37, no. 1, pp. 56–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Chalasani, M. A. Deeg, and D. W. Crabb, “Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis,” The American Journal of Gastroenterology, vol. 99, no. 8, pp. 1497–1502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. I. Miller, S.-H. Choi, P. Wiesner et al., “Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity,” Circulation Research, vol. 108, no. 2, pp. 235–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Weismann and C. J. Binder, “The innate immune response to products of phospholipid peroxidation,” Biochimica et Biophysica Acta, vol. 1818, no. 10, pp. 2465–2475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Tariq, C. J. Green, and L. Hodson, “Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?” Liver International, vol. 34, no. 7, pp. e180–e190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Takaki, D. Kawai, and K. Yamamoto, “Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH),” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 20704–20728, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Novo, C. Busletta, L. V. D. Bonzo et al., “Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells,” Journal of Hepatology, vol. 54, no. 5, pp. 964–974, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Novo, D. Povero, C. Busletta et al., “The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells,” The Journal of Pathology, vol. 226, no. 4, pp. 588–597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Chatterjee, D. Ganini, E. J. Tokar et al., “Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 58, no. 4, pp. 778–784, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Zielonka, A. Sikora, J. Joseph, and B. Kalyanaraman, “Peroxynitrite is the major species formed from different flux ratios of co-generated nitric oxide and superoxide: direct reaction with boronate-based fluorescent probe,” The Journal of Biological Chemistry, vol. 285, no. 19, pp. 14210–14216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Czaja, “Cell signaling in oxidative stress-induced liver injury,” Seminars in Liver Disease, vol. 27, no. 4, pp. 378–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Singh, Y. Wang, J. M. Schattenberg, Y. Xiang, and M. J. Czaja, “Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 297, no. 5, pp. G907–G917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Czaja, H. Liu, and Y. Wang, “Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling,” Hepatology, vol. 37, no. 6, pp. 1405–1413, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. S. R. Bruckner and S. Estus, “JNK3 contributes to c-jun induction and apoptosis in 4-hydroxynonenal-treated sympathetic neurons,” Journal of Neuroscience Research, vol. 70, no. 5, pp. 665–670, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Parola, G. Robino, F. Marra et al., “HNE interacts directly with JNK isoforms in human hepatic stellate cells,” The Journal of Clinical Investigation, vol. 102, no. 11, pp. 1942–1950, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. B. A. Neuschwander-Tetri, “Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH,” Current Gastroenterology Reports, vol. 12, no. 1, pp. 49–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. B. A. Neuschwander-Tetri, “Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites,” Hepatology, vol. 52, no. 2, pp. 774–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Cusi, “Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications,” Gastroenterology, vol. 142, no. 4, pp. 711.e6–725.e6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Farrell, “Should we lower lipids in nonalcoholic fatty liver disease?” Clinical Gastroenterology and Hepatology, vol. 12, no. 1, pp. 152–155, 2014. View at Publisher · View at Google Scholar
  49. P. Puri, R. A. Baillie, M. M. Wiest et al., “A lipidomic analysis of nonalcoholic fatty liver disease,” Hepatology, vol. 46, no. 4, pp. 1081–1090, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. D. M. van Rooyen, C. Z. Larter, W. G. Haigh et al., “Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis,” Gastroenterology, vol. 141, no. 4, pp. 1393.e5–1403.e5, 2011. View at Google Scholar · View at Scopus
  51. F. Caballero, A. Fernández, A. M. De Lacy, J. C. Fernández-Checa, J. Caballería, and C. García-Ruiz, “Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH,” Journal of Hepatology, vol. 50, no. 4, pp. 789–796, 2009. View at Publisher · View at Google Scholar
  52. L. T. Gan, D. M. Van Rooyen, M. E. Koina, R. S. McCuskey, N. C. Teoh, and G. C. Farrell, “Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent,” Journal of Hepatology, vol. 61, no. 6, pp. 1376–1384, 2014. View at Publisher · View at Google Scholar
  53. M. Amir, K. Liu, E. Zhao, and M. J. Czaja, “Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death,” Journal of Cellular Biochemistry, vol. 113, no. 10, pp. 3254–3265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Davidovich, C. J. Kearney, and S. J. Martin, “Inflammatory outcomes of apoptosis, necrosis and necroptosis,” Biological Chemistry, vol. 395, no. 10, pp. 1163–1171, 2014. View at Publisher · View at Google Scholar
  55. P. Matzinger, “Friendly and dangerous signals: is the tissue in control?” Nature Immunology, vol. 8, no. 1, pp. 11–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. E. Bianchi, “DAMPs, PAMPs and alarmins: all we need to know about danger,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Yang, G. de la Rosa, P. Tewary, and J. J. Oppenheim, “Alarmins link neutrophils and dendritic cells,” Trends in Immunology, vol. 30, no. 11, pp. 531–537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. D. L. Rosin and M. D. Okusa, “Dangers within: DAMP responses to damage and cell death in kidney disease,” Journal of the American Society of Nephrology, vol. 22, no. 3, pp. 416–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Kono and K. L. Rock, “How dying cells alert the immune system to danger,” Nature Reviews Immunology, vol. 8, no. 4, pp. 279–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Matzinger, “An innate sense of danger,” Annals of the New York Academy of Sciences, vol. 961, pp. 341–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. S.-Y. Seong and P. Matzinger, “Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses,” Nature Reviews Immunology, vol. 4, no. 6, pp. 469–478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Xiang and J. Fan, “Pattern recognition receptor-dependent mechanisms of acute lung injury,” Molecular Medicine, vol. 16, no. 1-2, pp. 68–82, 2010. View at Publisher · View at Google Scholar
  63. J. Hewinson, S. F. Moore, C. Glover, A. G. Watts, and A. B. MacKenzie, “A key role for redox signaling in rapid P2X7 receptor-induced IL-1β processing in human monocytes,” Journal of Immunology, vol. 180, no. 12, pp. 8410–8420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J. M. Kahlenberg and G. R. Dubyak, “Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release,” The American Journal of Physiology—Cell Physiology, vol. 286, no. 5, pp. C1100–C1108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp, “Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration,” Cell Death and Differentiation, vol. 14, no. 9, pp. 1583–1589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Suzuki, I. Hide, K. Ido, S. Kohsaka, K. Inoue, and Y. Nakata, “Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia,” The Journal of Neuroscience, vol. 24, no. 1, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. L. K. Parvathenani, S. Tertyshnikova, C. R. Greco, S. B. Roberts, B. Robertson, and R. Posmantur, “P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease,” The Journal of Biological Chemistry, vol. 278, no. 15, pp. 13309–13317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. X. Wang, P. Svedin, C. Nie et al., “N-Acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury,” Annals of Neurology, vol. 61, no. 3, pp. 263–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. M. E. Killeen, L. Ferris, E. A. Kupetsky, L. Falo Jr., and A. R. Mathers, “Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis,” Journal of Immunology, vol. 190, no. 8, pp. 4324–4336, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. L. M. Hill, M. L. Gavala, L. Y. Lenertz, and P. J. Bertics, “Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes,” Journal of Immunology, vol. 185, no. 5, pp. 3028–3034, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Choi and A. M. Diehl, “Role of inflammation in nonalcoholic steatohepatitis,” Current Opinion in Gastroenterology, vol. 21, no. 6, pp. 702–707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. A. M. Diehl, Z. P. Li, H. Z. Lin, and S. Q. Yang, “Cytokines and the pathogenesis of non-alcoholic steatohepatitis,” Gut, vol. 54, no. 2, pp. 303–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Tilg and A. M. Diehl, “Cytokines in alcoholic and nonalcoholic steatohepatitis,” The New England Journal of Medicine, vol. 343, no. 20, pp. 1467–1467, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Chatterjee, R. Rana, J. Corbett, M. B. Kadiiska, J. Goldstein, and R. P. Mason, “P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice,” Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1666–1679, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Das, R. K. Seth, A. Kumar et al., “Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 305, no. 12, pp. G950–G963, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Takenouchi, M. Nakai, Y. Iwamaru et al., “The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells,” Journal of Immunology, vol. 182, no. 4, pp. 2051–2062, 2009. View at Google Scholar · View at Scopus
  77. R. Kiffin, C. Christian, E. Knecht, and A. M. Cuervo, “Activation of chaperone-mediated autophagy during oxidative stress,” Molecular Biology of the Cell, vol. 15, no. 11, pp. 4829–4840, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Das, A. Kumar, R. K. Seth et al., “Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity,” Toxicology and Applied Pharmacology, vol. 269, no. 3, pp. 297–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. V. Deretic, “Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors,” Current Opinion in Immunology, vol. 24, no. 1, pp. 21–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Fortunato and G. Kroemer, “Impaired autophagosome-lysosome fusion in the pathogenesis of pancreatitis,” Autophagy, vol. 5, no. 6, pp. 850–853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Nakahira, J. A. Haspel, V. A. K. Rathinam et al., “Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome,” Nature Immunology, vol. 12, no. 3, pp. 222–230, 2011. View at Publisher · View at Google Scholar · View at Scopus